Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

Stopped Informed by manufacturer that CDB-2914 crosses blood-brain barrier invalidating Arm #3 of protocol.

Conditions

• Premenstrual Syndrome
• PMS
• Premenstrual Dysphoric Disorder
• PMDD
• Depression

Interventions

• DRUG: Ethinyl Estradiol/Drospirenone
• DRUG: Placebo
• DRUG: CDB 2914

Sponsor

National Institute of Mental Health (NIMH)